{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:56:34Z","timestamp":1783389394223,"version":"3.54.6"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210407","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T04:06:27Z","timestamp":1546920387000},"page":"e0210407","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Validation of Multiplex Serology for human hepatitis viruses B and C, human T-lymphotropic virus 1 and Toxoplasma gondii"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7690-4925","authenticated-orcid":true,"given":"Nicole","family":"Brenner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Mentzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin L.","family":"Braband","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Jeffery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Klenerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"G\u00e4rtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Schnitzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Demontis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Hadfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Almond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pawlita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Waterboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1373\/clinchem.2005.052381","article-title":"Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins","volume":"51","author":"T Waterboer","year":"2005","journal-title":"Clinical chemistry"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1523-5378.2009.00723.x","article-title":"Helicobacter pylori multiplex serology","volume":"14","author":"A Michel","year":"2009","journal-title":"Helicobacter"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/aje\/kwv155","article-title":"Seroepidemiology of Human Polyomaviruses in a US Population","volume":"183","author":"A Gossai","year":"2016","journal-title":"American journal of epidemiology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/aje\/kwv281","article-title":"The Natural History of Human Polyomaviruses and Herpesviruses in Early Life\u2013The Rhea Birth Cohort in Greece","volume":"183","author":"M Karachaliou","year":"2016","journal-title":"American journal of epidemiology"},{"key":"ref5","article-title":"Virus taxonomy: ninth report of the International Committee on Taxonomy of Viruses","author":"AM King","year":"2011"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"a024935","DOI":"10.1101\/cshperspect.a024935","article-title":"Viral hepatitis B: clinical and epidemiological characteristics","volume":"4","author":"GS Burns","year":"2014","journal-title":"Cold Spring Harbor perspectives in medicine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.4254\/wjh.v9.i33.1239","article-title":"Global elimination of hepatitis C virus infection: Progresses and the remaining challenges","volume":"9","author":"R Taherkhani","year":"2017","journal-title":"World journal of hepatology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1098\/rspb.1993.0102","article-title":"The influence of age on the development of the hepatitis B carrier state","volume":"253","author":"WJ Edmunds","year":"1993","journal-title":"Proceedings Biological sciences"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/151.4.599","article-title":"Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state","volume":"151","author":"BJ McMahon","year":"1985","journal-title":"The Journal of infectious diseases"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(03)15109-4","article-title":"Viral hepatitis C","volume":"362","author":"T Poynard","year":"2003","journal-title":"Lancet (London, England)"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep.510290311","article-title":"Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection","volume":"29","author":"SA Villano","year":"1999","journal-title":"Hepatology (Baltimore, Md)"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1136\/gut.34.2_Suppl.S17","article-title":"Community acquired viral hepatitis B and C in the United States","volume":"34","author":"MJ Alter","year":"1993","journal-title":"Gut"},{"key":"ref13","unstructured":"IARC. IARC Monograph Volume 100B; 2012. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/monographs.iarc.fr\/wp-content\/uploads\/2018\/06\/mono100B.pdf\" xlink:type=\"simple\">https:\/\/monographs.iarc.fr\/wp-content\/uploads\/2018\/06\/mono100B.pdf<\/ext-link>."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2013Part B: biological agents","volume":"10","author":"V Bouvard","year":"2009","journal-title":"The Lancet Oncology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"A Schweitzer","year":"2015","journal-title":"Lancet (London, England)"},{"key":"ref16","article-title":"Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide","author":"D Maucort-Boulch","year":"2018","journal-title":"International journal of cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"E Gower","year":"2014","journal-title":"Journal of hepatology"},{"key":"ref18","article-title":"Hepatitis C in the UK","author":"PH England","year":"2017","journal-title":"Hepatitis C in the UK"},{"key":"ref19","article-title":"Direct-acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease","author":"LI Backus","year":"2018","journal-title":"Hepatology (Baltimore, Md)"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5114\/ceh.2017.67626","article-title":"Recommendations for the treatment of hepatitis B in 2017","volume":"3","author":"R Flisiak","year":"2017","journal-title":"Clinical and experimental hepatology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.coviro.2017.03.014","article-title":"Designing an HCV vaccine: a unique convergence of prevention and therapy?","volume":"23","author":"CM Walker","year":"2017","journal-title":"Current opinion in virology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJM198010093031501","article-title":"Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States","volume":"303","author":"W Szmuness","year":"1980","journal-title":"The New England journal of medicine"},{"key":"ref23","first-page":"g2522","article-title":"Ordering and interpreting hepatitis B serology","volume":"348","author":"SA Davison","year":"2014","journal-title":"BMJ (Clinical research ed)"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.antiviral.2016.10.015","article-title":"Reducing the global burden of HTLV-1 infection: An agenda for research and action","volume":"137","author":"L Willems","year":"2017","journal-title":"Antiviral research"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"M Osame","year":"1986","journal-title":"Lancet (London, England)"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev.immunol.15.1.15","article-title":"Human T cell leukemia virus type I (HTLV-I) and human diseases","volume":"15","author":"T Uchiyama","year":"1997","journal-title":"Annual review of immunology"},{"key":"ref27","first-page":"1096","article-title":"The risk of development of HTLV-I-associated myelopathy\/tropical spastic paraparesis among persons infected with HTLV-I","volume":"3","author":"JE Kaplan","year":"1990","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/bmj.320.7235.611","article-title":"HTLV-I\/II associated disease in England and Wales, 1993\u20137: retrospective review of serology requests","volume":"320","author":"JH Tosswill","year":"2000","journal-title":"BMJ (Clinical research ed)"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.exppara.2013.10.001","article-title":"Toxoplasma gondii infection: What is the real situation?","volume":"135","author":"W Chemoh","year":"2013","journal-title":"Experimental parasitology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(96)11105-3","article-title":"Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team","volume":"350","author":"WR Bowie","year":"1997","journal-title":"Lancet (London, England)"},{"key":"ref31","article-title":"Advances in serological, imaging techniques and molecular diagnosis of Toxoplasma gondii infection","author":"A Rostami","year":"2018","journal-title":"Infection"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3201\/eid0911.030143","article-title":"Toxoplasma gondii and schizophrenia","volume":"9","author":"EF Torrey","year":"2003","journal-title":"Emerging infectious diseases"},{"key":"ref33","article-title":"Toxoplasma gondii infection and behavioral outcomes in humans: a systematic review","author":"VO Martinez","year":"2018","journal-title":"Parasitology research"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/B978-0-444-53490-3.00008-X","article-title":"Toxoplasmosis","volume":"114","author":"SK Halonen","year":"2013","journal-title":"Handbook of clinical neurology"},{"key":"ref35","unstructured":"Centers for Disease Control and Prevention. Parasites\u2014Toxoplasmosis (Toxoplasma infection); Resources for Health Professionals;. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cdc.gov\/parasites\/toxoplasmosis\/health_professionals\/index.html#tx\" xlink:type=\"simple\">https:\/\/www.cdc.gov\/parasites\/toxoplasmosis\/health_professionals\/index.html#tx<\/ext-link>."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","article-title":"Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis","volume":"39","author":"G Pappas","year":"2009","journal-title":"International journal for parasitology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-1759(01)00376-3","article-title":"A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology","volume":"253","author":"P Sehr","year":"2001","journal-title":"Journal of immunological methods"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1158\/1055-9965.EPI-15-0351","article-title":"et al. Hepatitis C Virus Seroprevalence in Mongolian Women Assessed by a Novel Multiplex Antibody Detection Assay","volume":"24","author":"B Dondog","year":"2015","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1128\/JVI.74.5.2193-2202.2000","article-title":"The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro","volume":"74","author":"CT Bock","year":"2000","journal-title":"Journal of virology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1099\/vir.0.012740-0","article-title":"Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication","volume":"91","author":"C Wu","year":"2010","journal-title":"The Journal of general virology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1128\/JCM.42.11.5133-5138.2004","article-title":"Evaluation of a candidate international standard preparation for human anti-Toxoplasma immunoglobulin G","volume":"42","author":"P Rigsby","year":"2004","journal-title":"Journal of clinical microbiology"},{"key":"ref42","first-page":"360","article-title":"Understanding interobserver agreement: the kappa statistic","volume":"37","author":"AJ Viera","year":"2005","journal-title":"Family medicine"},{"key":"ref43","article-title":"psych: Procedures for Psychological, Psychometric, and Personality Research. Evanston, Illinois; 2018","author":"W Revelle","year":"2018","journal-title":"R package version 1.8.4."},{"key":"ref44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research","volume":"15","author":"TK Koo","year":"2016","journal-title":"Journal of chiropractic medicine"},{"key":"ref45","article-title":"Interpretation of Hepatitis B Serologic Test Results","year":"2005","journal-title":"Interpretation of Hepatitis B Serologic Test Results"},{"issue":"Pt 3","key":"ref46","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1099\/0022-1317-80-3-727","article-title":"Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA","volume":"80","author":"M Rodr\u00edguez-L\u00f3pez","year":"1999","journal-title":"The Journal of general virology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1099\/vir.0.010199-0","article-title":"HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes","volume":"90","author":"K Suemori","year":"2009","journal-title":"The Journal of general virology"},{"key":"ref48","first-page":"361","article-title":"Antibodies to the envelope glycoprotein of human T cell leukemia virus type 1 robustly activate cell-mediated cytotoxic responses and directly neutralize viral infectivity at multiple steps of the entry process","volume":"187","author":"CWS Kuo","year":"2011","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-3083.1994.tb03447.x","article-title":"Comparative analysis of the antibody response to the HTLV-I gag and env proteins in HTLV-I asymptomatic carriers and HAM\/TSP patients: an isotype and subclass analysis","volume":"40","author":"GA Dekaban","year":"1994","journal-title":"Scandinavian journal of immunology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<196::AID-IJC12>3.0.CO;2-G","article-title":"Antibody reactivities to tumor-suppressor protein p53 and HTLV-I Tof, Rex and Tax in HTLV-I-infected people with differing clinical status","volume":"71","author":"YM Chen","year":"1997","journal-title":"International journal of cancer"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.exppara.2006.02.005","article-title":"Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model","volume":"114","author":"H Siachoque","year":"2006","journal-title":"Experimental parasitology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.vaccine.2009.12.005","article-title":"Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB\/c mice model","volume":"28","author":"R Fang","year":"2010","journal-title":"Vaccine"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infection\u2013natural history and clinical consequences","volume":"350","author":"D Ganem","year":"2004","journal-title":"The New England journal of medicine"},{"key":"ref54","unstructured":"ABBOTT Diagnostics Division, Anti-HCV; 2009. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ilexmedical.com\/files\/PDF\/AntiHCV_ARC.pdf\" xlink:type=\"simple\">www.ilexmedical.com\/files\/PDF\/AntiHCV_ARC.pdf<\/ext-link>."},{"key":"ref55","unstructured":"Diasorin. Murex anti-HCV;. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.diasorin.com\/sites\/default\/files\/allegati_prodotti\/Murex%20Anti-HCV%20Version%204.0.pdf\" xlink:type=\"simple\">https:\/\/www.diasorin.com\/sites\/default\/files\/allegati_prodotti\/Murex%20Anti-HCV%20Version%204.0.pdf<\/ext-link>."},{"key":"ref56","unstructured":"Division AD. HCV version 3.0;. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ilexmedical.com\/files\/PDF\/HCV3.pdf\" xlink:type=\"simple\">http:\/\/www.ilexmedical.com\/files\/PDF\/HCV3.pdf<\/ext-link>."},{"issue":"Pt 1","key":"ref57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0031182000066695","article-title":"Surface antigens of Toxoplasma gondii","volume":"97","author":"G Couvreur","year":"1988","journal-title":"Parasitology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.exppara.2008.03.016","article-title":"Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris","volume":"119","author":"YL Lau","year":"2008","journal-title":"Experimental parasitology"},{"key":"ref59","article-title":"Serologic markers of viral infection and risk of non-Hodgkin lymphoma: A pooled study of three prospective cohorts in China and Singapore","author":"BA Bassig","year":"2018","journal-title":"International journal of cancer"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13027-017-0121-1","article-title":"Hepatitis C virus seroprevalence in the general female population of 9 countries in Europe, Asia and Africa","volume":"12","author":"GM Clifford","year":"2017","journal-title":"Infectious agents and cancer"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1158\/1055-9965.EPI-12-0651","article-title":"No association between antibodies to sexually transmitted infections and colorectal hyperplastic polyps in men: Minnesota Cancer Prevention Research Unit Polyp Study","volume":"21","author":"AN Burnett-Hartman","year":"2012","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:59:09Z","timestamp":1589021949000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210407"}},"subtitle":[],"editor":[{"given":"Isabelle","family":"Chemin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210407","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]}}}